Go Pro

Cullinan Therapeutics (CGEM) Institutional Ownership

Cullinan Therapeutics logo
$21.71 -0.62 (-2.78%)
As of 02:39 PM Eastern

Institutional Ownership Changes (13F Filings) for Cullinan Therapeutics (NASDAQ:CGEM)

Current
Institutional Ownership
Percentage
86.31%
Number of
Institutional Buyers
(last 12 months)
87
Total
Institutional Inflows
(last 12 months)
$279.19M
Number of
Institutional Sellers
(last 12 months)
39
Total
Institutional Outflows
(last 12 months)
$70.55M
Get CGEM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cullinan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CGEM Institutional Buying and Selling by Quarter

Cullinan Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/27/2026 Corient Private Wealth LP54,877$999K0.0%+96.8%0.085%
8/24/2026 California State Teachers Retirement System733,007$13.35M0.0%+2,311.4%1.139%
8/21/2026 AXQ Capital LP14,935$272K0.0%N/A0.023%
8/21/2026 Pale Fire Capital SE12,418$226K0.0%-12.7%0.019%
8/20/2026 Moore Capital Management LP189,946$3.46M0.1%+79.3%0.295%
8/20/2026 Two Sigma Securities LLC15,220$277K0.0%N/A0.024%
8/19/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC84,178$1.53M0.0%+24.4%0.131%
8/19/2026 Wellington Management Group LLP164,716$3.00M0.0%+10.1%0.256%
8/17/2026 Corient Private Wealth LP53,282$970K0.0%N/A0.083%
8/17/2026 Bank of America Corp DE510,325$9.29M0.0%N/A0.793%
8/17/2026 Boone Capital Management LLC704,442$12.83M3.0%N/A1.095%
8/15/2026 Jupiter Topco LLC18,528$337K0.0%N/A0.029%
8/15/2026 Elmind Capital LP690,000$12.56M0.0%N/A1.072%
8/14/2026 Legal & General Group Plc27,477$500K0.0%N/A0.043%
8/14/2026 The Manufacturers Life Insurance Company 76,711$1.40M0.0%N/A0.119%
8/14/2026 Algert Global LLC36,851$671K0.0%-66.4%0.057%
8/13/2026 Connor Clark & Lunn Investment Management Ltd.292,500$5.33M0.0%N/A0.454%
8/12/2026 Quantbot Technologies LP2,911$53K0.0%N/A0.005%
8/12/2026 Ieq Capital LLC33,720$614K0.0%N/A0.052%
8/11/2026 Allworth Financial LP2,893$53K0.0%N/A0.004%
8/11/2026 Blue Owl Capital Holdings LP1,539,764$28.04M4.2%N/A2.392%
8/10/2026 Great Lakes Advisors LLC11,806$215K0.0%N/A0.018%
8/7/2026 BlackRock Inc.5,232,766$95.29M0.0%N/A8.514%
8/7/2026 Deutsche Bank AG382,840$6.97M0.0%N/A0.623%
8/6/2026 Bank of New York Mellon Corp171,031$3.11M0.0%N/A0.278%
7/8/2026 Assenagon Asset Management S.A.61,682$1.12M0.0%-55.5%0.100%
6/4/2026 Seven Fleet Capital Management LP1,844$26K0.0%-38.5%0.003%
5/19/2026 Bank of America Corp DE516,724$7.34M0.0%+49.2%0.841%
5/18/2026 Royal Bank of Canada4,044$58K0.0%+160.6%0.007%
5/18/2026 Elmind Capital LP530,000$7.53M2.1%+71.0%0.862%
5/16/2026 The Manufacturers Life Insurance Company75,310$1.07M0.0%+347.7%0.123%
5/16/2026 Quantinno Capital Management LP72,282$1.03M0.0%+50.6%0.118%
5/16/2026 Orbimed Advisors LLC243,006$3.45M0.1%-10.0%0.395%
5/15/2026 Affinity Asset Advisors LLC781,260$11.10M0.6%-59.6%1.271%
5/14/2026 Renaissance Technologies LLC324,111$4.61M0.0%-48.7%0.527%
5/14/2026 Pale Fire Capital SE14,218$202K0.0%-26.4%0.023%
5/14/2026 Knott David M Jr24,200$344K0.2%N/A0.039%
5/7/2026 Dimensional Fund Advisors LP906,028$12.87M0.0%+6.7%1.474%
5/7/2026 AlphaCentric Advisors LLC20,135$286K0.3%+5.7%0.033%
5/5/2026 Bank of New York Mellon Corp143,708$2.04M0.0%-0.8%0.234%
My top 3 AI picks for the next decade (Ad)

Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel

Click here to get all three AI stock names from Alexander Green
4/27/2026 Y Intercept Hong Kong Ltd95,417$1.36M0.0%N/A0.158%
4/27/2026 Leonteq Securities AG10,000$142K0.0%N/A0.017%
4/22/2026 Sterling Capital Management LLC1,799$26K0.0%-41.4%0.003%
4/20/2026 Assenagon Asset Management S.A.138,705$1.97M0.0%-12.6%0.229%
3/3/2026 Caitong International Asset Management Co. Ltd4,680$48K0.0%+181.9%0.008%
2/26/2026 Seven Fleet Capital Management LP3,000$31K0.0%N/A0.005%
2/19/2026 Invesco Ltd.130,323$1.35M0.0%+27.4%0.221%
2/18/2026 XTX Topco Ltd121,257$1.26M0.0%-27.8%0.205%
2/18/2026 Virtus Investment Advisers LLC22,318$231K0.1%+75.5%0.038%
2/18/2026 Wellington Management Group LLP159,751$1.65M0.0%-5.0%0.270%
2/18/2026 Susquehanna Portfolio Strategies LLC233,842$2.42M0.0%+87.8%0.396%
2/18/2026 Tudor Investment Corp ET AL10,128$105K0.0%-65.1%0.017%
2/18/2026 Orbimed Advisors LLC270,006$2.80M0.1%-86.0%0.457%
2/18/2026 Millennium Management LLC362,495$3.75M0.0%-34.1%0.614%
2/18/2026 Elmind Capital LP310,000$3.21M0.9%N/A0.525%
2/18/2026 Engineers Gate Manager LP69,343$718K0.0%+37.7%0.117%
2/18/2026 Boothbay Fund Management LLC1,237,043$12.80M0.2%N/A2.094%
2/17/2026 ADAR1 Capital Management LLC50,000$518K0.0%N/A0.085%
2/17/2026 Schonfeld Strategic Advisors LLC16,638$172K0.0%N/A0.028%
2/17/2026 AQR Capital Management LLC281,483$2.91M0.0%+42.2%0.476%
2/17/2026 Trexquant Investment LP381,535$3.95M0.0%+103.4%0.646%
2/17/2026 Jump Financial LLC364,889$3.78M0.0%+87.6%0.618%
2/17/2026 Price T Rowe Associates Inc. MD47,187$489K0.0%+9.1%0.080%
2/17/2026 Russell Investments Group Ltd.24,409$253K0.0%+471.4%0.041%
2/17/2026 ExodusPoint Capital Management LP30,487$316K0.0%N/A0.052%
2/16/2026 Squarepoint Ops LLC75,820$785K0.0%-16.1%0.128%
2/16/2026 Mariner LLC49,131$508K0.0%+74.5%0.083%
2/16/2026 Kennedy Capital Management LLC47,266$489K0.0%+2.7%0.080%
2/16/2026 Barclays PLC269,655$2.79M0.0%+7.4%0.456%
2/13/2026 Marshall Wace LLP414,359$4.29M0.0%+40.3%0.701%
2/13/2026 The Manufacturers Life Insurance Company 16,822$174K0.0%-5.6%0.028%
2/13/2026 Affinity Asset Advisors LLC1,932,106$20.00M1.1%+632.4%3.270%
2/13/2026 Quarry LP9,600$99K0.0%N/A0.016%
2/13/2026 Schroder Investment Management Group343,667$3.41M0.0%N/A0.582%
2/13/2026 Rafferty Asset Management LLC61,671$638K0.0%+51.4%0.104%
2/13/2026 Charles Schwab Investment Management Inc.436,273$4.52M0.0%+8.4%0.738%
2/13/2026 State Street Corp2,197,338$22.74M0.0%+31.0%3.719%
2/13/2026 Caitong International Asset Management Co. Ltd2,696$28K0.1%+62.4%0.005%
2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC48,051$497K0.0%+1.9%0.081%
2/13/2026 Wells Fargo & Company MN60,514$626K0.0%+54.7%0.102%
2/12/2026 HRT Financial LP84,067$870K0.0%+99.6%0.142%
2/12/2026 MetLife Investment Management LLC30,816$319K0.0%+32.6%0.052%
2/12/2026 Renaissance Technologies LLC631,706$6.54M0.0%+19.3%1.069%
2/12/2026 Dimensional Fund Advisors LP848,769$8.78M0.0%-28.3%1.437%
2/12/2026 EntryPoint Capital LLC23,788$246K0.1%-43.6%0.040%
2/12/2026 AlphaCentric Advisors LLC19,041$197K0.2%N/A0.032%
2/12/2026 Swiss National Bank58,300$603K0.0%+15.9%0.099%
2/12/2026 Great Lakes Advisors LLC12,403$128K0.0%N/A0.021%
2/12/2026 Nuveen LLC579,095$5.99M0.0%+168.6%0.980%
2/11/2026 Deutsche Bank AG586,636$6.07M0.0%+2.6%0.993%
Porter flew 3,300 miles to investigate this system (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
2/11/2026 Fox Run Management L.L.C.21,204$219K0.0%+36.6%0.036%
2/10/2026 Goldman Sachs Group Inc.721,864$7.47M0.0%-26.6%1.222%
2/9/2026 Geode Capital Management LLC1,302,262$13.48M0.0%+0.5%2.204%
2/9/2026 Blue Owl Capital Holdings LP2,350,972$24.33M1.8%-6.4%3.979%
2/6/2026 Nano Cap New Millennium Growth Fund L P10,000$104K0.1%N/A0.017%
2/6/2026 ProShare Advisors LLC12,489$129K0.0%+15.3%0.021%
1/29/2026 UBS Group AG271,736$2.81M0.0%+44.4%0.460%
1/27/2026 Zurcher Kantonalbank Zurich Cantonalbank9,909$103K0.0%+29.7%0.017%
1/26/2026CWM LLC3,876$40K0.0%+51.5%0.007%
1/20/2026 Signaturefd LLC4,130$43K0.0%+689.7%0.007%


CGEM Institutional Ownership - Frequently Asked Questions

During the previous two years, 159 institutional investors and hedge funds held shares of Cullinan Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($95.29M), Deerfield Management Company L.P. Series C ($41.16M), Lynx1 Capital Management LP ($34.19M), RTW Investments LP ($28.56M), Blue Owl Capital Holdings LP ($28.04M), Holocene Advisors LP ($25.67M), and Alliancebernstein L.P. ($24.50M).Learn more on Cullinan Therapeutics' institutional investors.

86.31% of Cullinan Therapeutics' stock is owned by institutional investors. Learn more on CGEM's institutional investor holdings.

Of the 144 institutional investors that purchased Cullinan Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($5.23M), Lynx1 Capital Management LP ($2.21M), Blue Owl Capital Holdings LP ($2.02M), Affinity Asset Advisors LLC ($1.67M), Boothbay Fund Management LLC ($1.24M), Elmind Capital LP ($1.22M), and Braidwell LP ($1M).

Institutional investors have bought a total of 19,830,685 shares in the last 24 months. This purchase volume represents approximately $279.19M in transactions.

Of the 39 institutional investors that sold Cullinan Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($1.68M), Affinity Asset Advisors LLC ($1.15M), Deerfield Management Company L.P. ($928.54K), Franklin Resources Inc. ($812.12K), Citadel Advisors LLC ($465.39K), Dimensional Fund Advisors LP ($427.77K), and Renaissance Technologies LLC ($307.60K).

Institutional investors have sold a total of 7,437,561 shares in the last 24 months. This volume of shares sold represents approximately $70.55M in transactions.



Institutional ownership data for NASDAQ:CGEM is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/27/2026. New 13F filings are added each quarter as they're published.
From Our Partners